Cargando…
A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota
Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913869/ https://www.ncbi.nlm.nih.gov/pubmed/36766753 http://dx.doi.org/10.3390/cells12030411 |
_version_ | 1784885532547874816 |
---|---|
author | Suriano, Francesco Manca, Claudia Flamand, Nicolas Van Hul, Matthias Delzenne, Nathalie M. Silvestri, Cristoforo Cani, Patrice D. Di Marzo, Vincenzo |
author_facet | Suriano, Francesco Manca, Claudia Flamand, Nicolas Van Hul, Matthias Delzenne, Nathalie M. Silvestri, Cristoforo Cani, Patrice D. Di Marzo, Vincenzo |
author_sort | Suriano, Francesco |
collection | PubMed |
description | Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study, we characterized the profile of the eCBome and related oxylipins in the small and large intestines of genetically obese (ob/ob) and diabetic (db/db) mice to decipher possible correlations between these mediators and intestinal inflammation and gut microbiota composition. Basal lipid and gene expression profiles, measured by LC/MS-MS-based targeted lipidomics and qPCR transcriptomics, respectively, highlighted a differentially altered intestinal eCBome and oxylipin tone, possibly linked to increased mRNA levels of inflammatory markers in db/db mice. In particular, the duodenal levels of several 2-monoacylglycerols and N-acylethanolamines were increased and decreased, respectively, in db/db mice, which displayed more pronounced intestinal inflammation. To a little extent, these differences were explained by changes in the expression of the corresponding metabolic enzymes. Correlation analyses suggested possible interactions between eCBome/oxylipin mediators, cytokines, and bacterial components and bacterial taxa closely related to intestinal inflammation. Collectively, this study reveals that db/db mice present a higher inflammatory state in the intestine as compared to ob/ob mice, and that this difference is associated with profound and potentially adaptive or maladaptive, and partly intestinal segment-specific alterations in eCBome and oxylipin signaling. This study opens the way to future investigations on the biological role of several poorly investigated eCBome mediators and oxylipins in the context of obesity and diabetes-induced gut dysbiosis and inflammation. |
format | Online Article Text |
id | pubmed-9913869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99138692023-02-11 A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota Suriano, Francesco Manca, Claudia Flamand, Nicolas Van Hul, Matthias Delzenne, Nathalie M. Silvestri, Cristoforo Cani, Patrice D. Di Marzo, Vincenzo Cells Article Obesity is associated with a cluster of metabolic disorders, chronic low-grade inflammation, altered gut microbiota, increased intestinal permeability, and alterations of the lipid mediators of the expanded endocannabinoid (eCB) signaling system, or endocannabinoidome (eCBome). In the present study, we characterized the profile of the eCBome and related oxylipins in the small and large intestines of genetically obese (ob/ob) and diabetic (db/db) mice to decipher possible correlations between these mediators and intestinal inflammation and gut microbiota composition. Basal lipid and gene expression profiles, measured by LC/MS-MS-based targeted lipidomics and qPCR transcriptomics, respectively, highlighted a differentially altered intestinal eCBome and oxylipin tone, possibly linked to increased mRNA levels of inflammatory markers in db/db mice. In particular, the duodenal levels of several 2-monoacylglycerols and N-acylethanolamines were increased and decreased, respectively, in db/db mice, which displayed more pronounced intestinal inflammation. To a little extent, these differences were explained by changes in the expression of the corresponding metabolic enzymes. Correlation analyses suggested possible interactions between eCBome/oxylipin mediators, cytokines, and bacterial components and bacterial taxa closely related to intestinal inflammation. Collectively, this study reveals that db/db mice present a higher inflammatory state in the intestine as compared to ob/ob mice, and that this difference is associated with profound and potentially adaptive or maladaptive, and partly intestinal segment-specific alterations in eCBome and oxylipin signaling. This study opens the way to future investigations on the biological role of several poorly investigated eCBome mediators and oxylipins in the context of obesity and diabetes-induced gut dysbiosis and inflammation. MDPI 2023-01-25 /pmc/articles/PMC9913869/ /pubmed/36766753 http://dx.doi.org/10.3390/cells12030411 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Suriano, Francesco Manca, Claudia Flamand, Nicolas Van Hul, Matthias Delzenne, Nathalie M. Silvestri, Cristoforo Cani, Patrice D. Di Marzo, Vincenzo A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota |
title | A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota |
title_full | A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota |
title_fullStr | A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota |
title_full_unstemmed | A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota |
title_short | A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (ob/ob) and Diabetic (db/db) Mice: Links with Inflammation and Gut Microbiota |
title_sort | lipidomics- and transcriptomics-based analysis of the intestine of genetically obese (ob/ob) and diabetic (db/db) mice: links with inflammation and gut microbiota |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913869/ https://www.ncbi.nlm.nih.gov/pubmed/36766753 http://dx.doi.org/10.3390/cells12030411 |
work_keys_str_mv | AT surianofrancesco alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT mancaclaudia alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT flamandnicolas alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT vanhulmatthias alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT delzennenathaliem alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT silvestricristoforo alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT canipatriced alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT dimarzovincenzo alipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT surianofrancesco lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT mancaclaudia lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT flamandnicolas lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT vanhulmatthias lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT delzennenathaliem lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT silvestricristoforo lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT canipatriced lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota AT dimarzovincenzo lipidomicsandtranscriptomicsbasedanalysisoftheintestineofgeneticallyobeseobobanddiabeticdbdbmicelinkswithinflammationandgutmicrobiota |